News and reporting on cancer immunotherapy.
The consumer genetics firm will soon be able to team with other drug companies as it mines its genotypic database for new disease pathways.
The company has derived and validated a mutational and gene expression score that predicts immunotherapy benefit across tumor types.
PamGene, Alithea Genomics, Lausanne University get €1M for Pan-Cancer Blood Test
The Dutch-Swiss Mainline consortium plans to develop a multiomics model to guide immune checkpoint inhibitor therapy across a broad range of cancers.
Texas Research Institute, TGen, OncoHost Partner to ID Lung Cancer Resistance Mechanisms
Collaborators will study the immune profiles and molecular features of NSCLC to better understand patterns of response and resistance to immunotherapy.
Esophageal Cancer Molecular Study Highlights Tumor Subtypes, Treatment Response Markers
Researchers found four esophageal squamous cell carcinoma molecular subtypes by generating genomic, transcriptomic, epigenetic, and proteomic profiles for more than 150 cases.